Search Results - "COLLIER, Timothy J"
-
1
Aging and Parkinson's disease: Different sides of the same coin?
Published in Movement disorders (01-07-2017)“…ABSTRACT Despite abundant epidemiological evidence in support of aging as the primary risk factor for PD, biological correlates of a connection have been…”
Get full text
Journal Article -
2
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
Published in Neurobiology of disease (01-10-2015)“…Abstract Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn) into mice induce Parkinson's disease (PD)-like Lewy…”
Get full text
Journal Article -
3
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
Published in Journal of neuroinflammation (01-05-2018)“…Converging evidence suggests a role for microglia-mediated neuroinflammation in Parkinson's disease (PD). Animal models of PD can serve as a platform to…”
Get full text
Journal Article -
4
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
Published in Neurobiology of disease (01-10-2019)“…Animal models that accurately recapitulate the accumulation of alpha-synuclein (α-syn) inclusions, progressive neurodegeneration of the nigrostriatal system…”
Get full text
Journal Article -
5
Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat
Published in Neurobiology of disease (01-09-2011)“…Abstract Multiple laboratories have recently demonstrated that long-term dopaminergic transplants form Lewy bodies in patients with Parkinson's disease. Debate…”
Get full text
Journal Article -
6
Downregulation of striatal CaV1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age
Published in Neurobiology of disease (01-06-2023)“…In the past 25 years, the prevalence of Parkinson's disease (PD) has nearly doubled. Age remains the primary risk factor for PD and as the global aging…”
Get full text
Journal Article -
7
Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates
Published in Frontiers in neuroscience (29-01-2016)“…Accumulation of alpha-synuclein (α-syn) in Lewy bodies and neurites of midbrain dopamine neurons is diagnostic for Parkinson's disease (PD), leading to the…”
Get full text
Journal Article -
8
Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease
Published in The Journal of neuroscience (29-04-2020)“…The transcription factor Nurr1 has been identified to be ectopically induced in the striatum of rodents expressing l-DOPA-induced dyskinesia (LID). In the…”
Get full text
Journal Article -
9
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
Published in Movement disorders (01-05-2019)“…Background Levodopa‐induced dyskinesias are an often debilitating side effect of levodopa therapy in Parkinson's disease. Although up to 90% of individuals…”
Get full text
Journal Article -
10
Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration
Published in The Journal of neuroscience (12-07-2017)“…Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is the most common neurosurgical treatment for Parkinson's disease motor symptoms. In preclinical…”
Get full text
Journal Article -
11
The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats
Published in Neurobiology of disease (01-01-2021)“…Prevalent in approximately 20% of the worldwide human population, the rs6265 (also called ‘Val66Met’) single nucleotide polymorphism (SNP) in the gene for…”
Get full text
Journal Article -
12
Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing
Published in Methods in molecular biology (Clifton, N.J.) (2019)“…Clustered regularly interspaced short palindromic repeat (CRISPR/Cas) system has emerged as an extremely useful tool for biological research and as a potential…”
Get more information
Journal Article -
13
Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease
Published in The Journal of neuroscience (11-11-2015)“…The striatum is essential for many aspects of mammalian behavior, including motivation and movement, and is dysfunctional in motor disorders such as…”
Get full text
Journal Article -
14
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease
Published in JCI insight (08-03-2021)“…Parkinson's disease (PD) is a prevalent neurodegenerative disease with no approved disease-modifying therapies. Multiplications, mutations, and single…”
Get full text
Journal Article -
15
Behavioral phenotyping of a rat model of the BDNF Val66Met polymorphism reveals selective impairment of fear memory
Published in Translational psychiatry (07-03-2022)“…The common brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with reduced activity-dependent BDNF release and increased risk for…”
Get full text
Journal Article -
16
Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease
Published in Frontiers in neuroscience (04-09-2018)“…Animal models have significantly advanced our understanding of Parkinson's disease (PD). Alpha-synuclein (α-syn) has taken center stage due to its genetic…”
Get full text
Journal Article -
17
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form
Published in Neurobiology of disease (01-10-2017)“…The pathology of Parkinson's disease and other synucleinopathies is characterized by the formation of intracellular inclusions comprised primarily of…”
Get full text
Journal Article -
18
The longitudinal transcriptomic response of the substantia nigra to intrastriatal 6-hydroxydopamine reveals significant upregulation of regeneration-associated genes
Published in PloS one (20-05-2015)“…We hypothesized that the study of gene expression at 1, 2, 4, 6 and 16 weeks in the substantia nigra (SN) after intrastriatal 6-OHDA in the Sprague-Dawley rat…”
Get full text
Journal Article -
19
Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system
Published in Experimental neurology (01-04-2015)“…In addition to alleviating depression, trophic responses produced by antidepressants may regulate neural plasticity in the diseased brain, which not only…”
Get full text
Journal Article -
20
Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats
Published in NPJ Parkinson's Disease (23-08-2024)“…The rs6265 single nucleotide polymorphism (SNP) in the gene for brain-derived neurotrophic factor is a common variant that alters therapeutic outcomes for…”
Get full text
Journal Article